Fulcrum Genomics

Executive Summary

Fulcrum Genomics is a San Francisco-based bioinformatics consulting and software development firm founded in 2015. The company provides expert computational biology services and custom genomic analysis tools to clients in research, diagnostics, and therapeutics. Its core mission is to translate complex molecular data into actionable biological insights, enabling advancements in precision medicine. As a private entity with no disclosed funding or revenue, Fulcrum Genomics has established itself as a specialized partner for organizations seeking to leverage genomic data without building in-house bioinformatics capabilities. The company's expertise spans next-generation sequencing (NGS) analysis, variant interpretation, and pipeline development, positioning it as a key enabler in the genomics ecosystem.

Upcoming Catalysts (preview)

• Q2 2026Launch of an AI-Powered Genomic Analysis Platform70% success
• Q3 2026Strategic Partnership with a Leading Diagnostics Company60% success
• Q4 2026Entry into Clinical Diagnostics with FDA-Cleared Software50% success